Publications

Title

Author

Year

DISCOVERY OF NOVEL TRANSMISSION BLOCKING VACCINE CANDIDATES USING GAMETOCYTE PROTEIN MICROARRAY.

Stone, W; Campo, J; Morlais, I; Cohuet, A; Drakely, C; SUTHERLAND, C; Molina, D; Randall, A; Pablo, J; Hung, C; Shandling, A; Tettah, K; Janse, C; Khan, S; Lasonder, E; Sauerwein, R; Felgner, P; Bousema, T;

2015

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2015).93 4

Pneumococcal vaccination and childhood pneumonia in South Africa.

MULHOLLAND, K; Nguyen, C;

2015

Thorax, (2015).70 12 10.1136/thoraxjnl-2015-207191.

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.

SMITH, SG; Smits, K; Joosten, SA; Van Meijgaarden, KE; Satti, I; FLETCHER, HA; Caccamo, N; Dieli, F; Mascart, F; McShane, H; DOCKRELL, HM; Ottenhoff, TH M; TBVI TB Biomarker Working Group,;

2015

PloS one, (2015).10 9 10.1371/journal.pone.0138042.

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

GBD 2013 Risk Factors Collaborators,; Forouzanfar, MH; Alexander, L; Anderson, HR; Bachman, VF; Biryukov, S; Brauer, M; Burnett, R; Casey, D; Coates, MM; Cohen, A; Delwiche, K; Estep, K; Frostad, JJ; Astha, KC; Kyu, HH; Moradi-Lakeh, M; Ng, M; Slepak, EL; Thomas, BA; Wagner, J; Aasvang, GM; Abbafati, C; Abbasoglu Ozgoren, A; Abd-Allah, F; ... Murray, CJ.

2015

Lancet, (2015).386 10010 10.1016/S0140-6736(15)00128-2.

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.

Moody, MA; Gao, F; Gurley, TC; Amos, JD; Kumar, A; Hora, B; Marshall, DJ; Whitesides, JF; Xia, S-M; Parks, R; Lloyd, KE; Hwang, K-K; Lu, X; Bonsignori, M; Finzi, A; Vandergrift, NA; Alam, SM; Ferrari, G; Shen, X; Tomaras, GD; Kamanga, G; Cohen, MS; Sam, NE; KAPIGA, S; Gray, ES; ... Haynes, BF.

2015

Cell host & microbe, (2015).18 3 10.1016/j.chom.2015.08.006.

High-dose influenza vaccines make economic sense for older people.

JIT, M;

2015

The Lancet infectious diseases, (2015).15 12 10.1016/S1473-3099(15)00272-8.

The broader economic impact of vaccination: reviewing and appraising the strength of evidence.

JIT, M; Hutubessy, R; Png, ME; SUNDARAM, N; Audimulam, J; Salim, S; Yoong, J;

2015

BMC medicine, (2015).13 1 10.1186/s12916-015-0446-9.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.

White, MT; Verity, R; Griffin, JT; ASANTE, KP; OWUSU-AGYEI, S; GREENWOOD, B; DRAKELEY, C; Gesase, S; Lusingu, J; Ansong, D; Adjei, S; Agbenyega, T; Ogutu, B; Otieno, L; Otieno, W; Agnandji, ST; Lell, B; Kremsner, P; Hoffman, I; Martinson, F; Kamthunzu, P; Tinto, H; Valea, I; Sorgho, H; Oneko, M; ... Ghani, AC.

2015

The Lancet infectious diseases, (2015).15 12 10.1016/S1473-3099(15)00239-X.

Fewer than three doses of HPV vaccine.

JIT, M; Laprise, J-F; Choi, YH; Brisson, M;

2015

The lancet oncology, (2015).16 9 10.1016/S1470-2045(15)00229-6.

New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impacts.

TORRES-RUEDA, S; BURCHETT, HE; GRIFFITHS, UK; Ongolo-Zogo, P; Edengue, J-M; Kitaw, Y; Molla, M; Gelmon, L; Onyango-Ouma, W; Konate, M; MOUNIER-JACK, S;

2015

African health sciences, (2015).15 3 10.4314/ahs.v15i3.22.